Photo of Steven Boranian

A postal worker picks up a leaking bottle of drain cleaner stuck on a conveyor belt and suffers severe chemical burns.  The product was sold through an online marketplace and was made by a manufacturer that sells only bulk cases to hardware distributors.  This wayward bottle was shipped in the US Mail illegally by someone…

Photo of Bexis

There is still a lot of 2026 left, and the Blog has already published two posts discussing (among other things) informed consent claims brought against manufacturers of prescription medical products.  The first post reviewed Graw v. Eli Lilly & Co., 821 F. Supp.3d 981 (E.D. Mo. 2026), where the plaintiff unsuccessfully brought such a claim…

Photo of Steven Boranian

A recent order from the Northern District of Illinois shows just how far public entities will go in trying to spread blame for opioid use and abuse, and in Baltimore City Board of School Commissioners v. Publicis Health, LLC, the district court found that a group of school districts reached too far.  No. 24…

Photo of Michelle Yeary

Every good mystery needs a red herring. The suspicious houseguest. The gardener with the shaky alibi. The tanning lotion sitting quietly on the bathroom counter while the actual culprit — a chiropractor-prescribed anti-inflammatory cream applied minutes before the plaintiff’s collapse — walks right past the detectives without so much as a raised eyebrow. That is…

Photo of Michelle Yeary

Bespoke makes us think of tailoring, which makes us think of London’s Savile Row, which makes us think of Annie’s You’re Never Fully Dressed Without a Smile (“who cares what they’re wearing on Main Street or Savile Row”).  Which as it turns out is perfect for today’s case about a plaintiff who wanted the court…

This post is from the non-Reed Smith, non-Dechert , and non-Holland & Knight side of the blog. Everyone else is involved.

The Good, the Bad, and the Ugly is a classic Clint Eastwood spaghetti Western where even the Good may not be all good.  In California state court, a demurrer sustained is a defense win, right?  Although there are some bright spots, In re Ranitidine Cases is one of the ugliest defense wins we have seen in a while, providing leave to amend and a roadmap for further expansion of the Gilead duty-to-innovate.

Continue Reading Post-Gilead Heartburn in the California Ranitidine Litigation
Photo of Bexis

It seems like once every couple of weeks, we see a story about some plaintiff (such as this one) suing, or threatening to sue, a defendant product manufacturer over some product that, according to the plaintiff, “the company should have recalled sooner.”

That’s garbage.

There is no such claim.  Rather failure-to-recall theories are…